ZEALAND PHARMA A/S
Patent Owner
Stats
- 32 US PATENTS IN FORCE
- 7 US APPLICATIONS PENDING
- Mar 15, 2018 most recent publication
Details
- 32 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,970 Total Citation Count
- Apr 18, 2000 Earliest Filing
- 33 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0354,366 APPARATUS AND METHODS FOR ADMINISTERING A PHARMACEUTICAL AGENTNov 17, 15Dec 14, 17[A61B, A61M]
2016/0067,311 USE OF ELSIGLUTIDE TO TREAT GASTROINTESTINAL MUCOSITIS INCLUDING CHEMOTHERAPY-INDUCED DIARRHEASep 01, 15Mar 10, 16[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0000,883 COMBINATION OF ACYLATED GLUCAGON ANALOGUES WITH INSULIN ANALOGUESAbandonedSep 17, 15Jan 07, 16[A61K]
2014/0011,733 COMBINATION OF ACYLATED GLUCAGON ANALOGUES WITH INSULIN ANALOGUESAbandonedJan 20, 12Jan 09, 14[A61K, C07K]
2013/0210,722 METHODS FOR USING PEPTIDE AGONISTS HAVING GLP-1 ACTIVITYAbandonedMar 26, 13Aug 15, 13[A61K]
2012/0264,693 COMPOUNDS ACTING AS PEPTIDE GAP JUNCTION MODULATORS, AND USES THEREOFAbandonedJun 11, 10Oct 18, 12[A61K, C12N, A61P, C07K]
2011/0312,878 PHARMACOLOGICALLY ACTIVE PEPTIDE CONJUGATES HAVING A REDUCED TENDENCY TOWARDS ENZYMATIC HYDROLYSISAbandonedFeb 15, 11Dec 22, 11[A61K, C12P, A61P, C07K]
2010/0048,462 TRUNCATED PTH PEPTIDES WITH A CYCLIC CONFORMATIONAbandonedDec 06, 07Feb 25, 10[A61K, C07K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
